Register   |   Log In Contact Us
Or login with one of the following

Log in

 

SUO 2013 SUO 2013

14th Annual Meeting of the Society of Urologic Oncology (SUO)suo

December 4 - 6, 2013

Bethesda, MD USA

SUO 2013 - Session Highlights (Best Abstract Presentation): Experience with active surveillance (AS) in patients with renal mass > 4cm: Assessment of growth kinetics and outcomes

BETHESDA, MD USA (UroToday.com) - Dr. Reza Mehrazin and colleagues from Fox Chase Cancer Center presented one of the largest series of active surveillance in renal masses > 4cm.>

Read more...

SUO 2013 - Session Highlights: Evaluation of surveillance guidelines for renal cell carcinoma following partial nephrectomy

BETHESDA, MD USA (UroToday.com) - The numerous available strategies for surveillance following partial nephrectomy (PN) differ in both frequency and recommended imaging modalities.

Read more...

SUO 2013 - Session Highlights: Targeted magnetic resonance imaging/ultrasound fusion biopsy significantly outperforms random 12-core biopsy for prediction of total prostate cancer tumor volume

BETHESDA, MD USA (UroToday.com) - Targeted magnetic resonance imaging/ultrasound (MRI/US) fusion biopsy has been shown to allow for more optimal lesion targeting.

Read more...

SUO 2013 - Session Highlights: NEUACT, a phase 2 randomized, open-label trial of DN24-02 in patients with surgically resected HER2+ urothelial cancer (UC): Updated analysis of product parameters, HER2 expression and safety

BETHESDA, MD USA (UroToday.com) - Dr. Leonard Gomella, professor and chairman of department urology at Thomas Jefferson University, presented an updated analysis on a multicenter, phase 2 randomized, open-label trial of DN24-02 in patients with surgically resected HER2 (negative prognostic factor) UC.

Read more...

SUO 2013 - Session Highlights: The influence of race on RCC incidence and survival

BETHESDA, MD USA (UroToday.com) - The incidence of renal cell carcinoma (RCC) has clearly increased over the last decade, and some of this might be attributed to increased abdominal imaging and incidentalomas.

Read more...

SUO 2013 - Session Highlights: Comparative effectiveness research studies of robotic vs. open prostatectomy

BETHESDA, MD USA (UroToday.com) - William Lowrance, MD, MPH reviewed some of the data regarding robotic and open prostatectomy.

Read more...

SUO 2013 - Session Highlights: Multicenter retrospective experience in the surgical management of isolated nodal recurrences post-nephrectomy in patients with renal cell carcinoma

BETHESDA, MD USA (UroToday.com) - Up to 10-24% of patients treated surgically for clinically localized renal cell carcinoma can recur locally.

Read more...

SUO 2013 - Session Highlights: Prostate cancer microparticles as a next generation screening tool for prostate cancer

BETHESDA, MD USA (UroToday.com) - Dr. Khurram Siddiqui presented her project evaluating prostate cancer microparticles as a screening tool for prostate cancer detection.

Read more...

SUO 2013 - Session Highlights: Credentialing for robotic surgery

BETHESDA, MD USA (UroToday.com) - In the United States, there are approximately 2 robots per robotic surgeon, and currently no standardized credentialing system exists to evaluate surgeon competency and safety with robotic urological surgery performance.

Read more...

SUO 2013 - Session Highlights: Marketing robotic surgery

BETHESDA, MD USA (UroToday.com) - Vincent Laudone, MD gave an insightful review of marketing strategies employed by Intuitive Surgical, Inc., hospitals, and physicians which may have led to the early inappropriate adoption of robotic surgery in the absence of comparative data.

Read more...